NINJ2 rs12425791: Understanding Your Genetic Stroke Risk Marker
The rs12425791 variant is a single-nucleotide polymorphism located near the NINJ2 gene on chromosome 12. It has been identified in genome-wide association studies as a potential risk locus associated with the occurrence of ischemic stroke.
What each genotype means
Baseline stroke risk
This genotype represents the common baseline state for this genetic location. Research indicates that individuals without the risk-associated allele do not show the increased hazard ratio for ischemic stroke observed in carriers of the alternative allele.
This is the most common genotype in populations of European ancestry.
Increased stroke risk
Carrying one copy of the T allele has been associated with an increased risk of incident ischemic stroke in large-scale genomic studies. This association is statistical in nature and does not imply a diagnosis; please discuss your overall cardiovascular health and stroke risk factors with your healthcare provider.
This genotype is carried by a significant portion of the population, consistent with a minor allele frequency of approximately 0.15 to 0.20 in European ancestry groups.
Elevated stroke risk
Carrying two copies of the T allele is associated with a higher statistical risk of ischemic stroke compared to those without the allele. Because this is a complex trait influenced by many genetic and environmental factors, this result should be viewed as one small piece of your overall health profile and discussed with a clinician.
This genotype is less common than the heterozygous state, occurring at a frequency consistent with the reported minor allele frequency in European populations.
What is rs12425791?
The variant rs12425791 is a single-nucleotide polymorphism, or SNP, which is a common type of genetic variation where a single building block of DNA—a nucleotide—is replaced by another. This specific SNP is located in an intergenic region, meaning it sits in the DNA sequence between genes, specifically near the NINJ2 gene on chromosome 12. In genomics, variants in these non-coding regions are often investigated for their potential role in regulating the expression of nearby genes. While the variant itself does not code for a protein, researchers study it to understand how it might influence biological pathways that contribute to complex health conditions. It is important to note that identifying a SNP in a genome-wide association study (GWAS) indicates a statistical correlation with a trait, but it does not necessarily mean the variant directly causes the condition.
The Role of the NINJ2 Gene
The NINJ2 gene encodes a protein known as ninjurin-2. This protein is a member of the ninjurin family, which are transmembrane adhesion molecules. Research suggests that ninjurin-2 may play a role in nerve regeneration and cell-to-cell adhesion. Because the nervous system relies on complex signaling and structural integrity, proteins involved in nerve injury response and adhesion are of significant interest to researchers studying neurological health. While the exact mechanism by which the region near NINJ2 influences stroke risk remains a subject of ongoing investigation, the association between this genomic locus and vascular health has been highlighted in several large-scale studies. Scientists continue to explore whether the regulatory effects of variants near this gene impact how the body responds to vascular stress or injury.
Evidence and Research Context
The association between rs12425791 and ischemic stroke was identified through genome-wide association studies, which scan the genomes of large populations to find markers that appear more frequently in individuals with a specific condition. While these studies have provided evidence linking this locus to stroke risk, the strength of this evidence is generally considered limited. Stroke is a complex, multifactorial condition influenced by a combination of genetics, lifestyle factors, and environmental exposures. Genetic markers like rs12425791 represent only a small fraction of the overall heritability of stroke. Because these findings are based on statistical associations, they are not diagnostic tools. Researchers emphasize that while these genetic insights help map the biological landscape of stroke, they are not currently used to predict individual outcomes in a clinical setting.
What You Can Do With This Information
Understanding your genetic markers can be an educational experience, but it is vital to maintain perspective on what this information means for your health. A genetic variant like rs12425791 is not a medical diagnosis and does not determine your future health. If you have concerns about your risk for stroke, the most effective steps involve focusing on well-established, modifiable risk factors. These include maintaining healthy blood pressure, managing cholesterol levels, staying physically active, and avoiding smoking. Genetic data should never be used to make decisions about medication or lifestyle changes without consulting a healthcare professional. Always discuss your family history and any health concerns with your doctor, who can provide personalized guidance based on your overall clinical profile rather than a single genetic marker.
How common is this variant?
The minor allele frequency for rs12425791 is approximately 0.15 to 0.20 in populations of European ancestry.
Frequently asked questions
Does having the rs12425791 variant mean I will have a stroke?
No. Genetic variants identified in association studies indicate a statistical correlation with a trait, not a direct cause. Most people with this variant will never experience a stroke, and many who have strokes do not carry this specific marker.
Can I use this SNP to predict my stroke risk?
Currently, this SNP is not used for clinical risk prediction. Stroke risk is determined by many factors, including age, blood pressure, diet, and smoking status, which are far more predictive than this single genetic variant.
Where can I find more information about NINJ2?
You can visit the UniProt or NCBI Gene databases for detailed information on the function and expression of the NINJ2 gene. These resources provide comprehensive scientific data on human genes and proteins.
Should I change my medication based on this result?
Absolutely not. Never change or stop any medication based on genetic test results without speaking to your doctor or pharmacist. Genetic markers are not currently used to guide stroke-related medication dosing.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12425791?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29